Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Moderate-to-vigorous physical activity cardioprotective in lupus patients

25 Dec 2019

Physical activities (PA) of moderate-to-vigorous intensity confer protection against cardiovascular risk factors in patients with systemic lupus erythematosus (SLE), a study has found.

Researchers measured time in sedentary behaviour, light PA and moderate-to-vigorous PA (MVPA) in 100 SLE patients (mean age, 52.4 years; 92 percent female) who were free of cardiovascular disease (CVD) using accelerometry. They also assessed cardiovascular risk factors were measured, including body mass index (BMI), blood pressure, fasting glucose and lipid profile.

Accelerometer data showed that the mean total sedentary time was 10 hours/day, and the time spent in MVPA was low at a mean of 33.2 minutes/day. Only 11 participants met current PA recommendations (150 MVPA minutes/week in 10-minute bouts).

The 10-year risk of CVD (estimated using the American College of Cardiology/American Heart Association risk assessment tool) was low in the majority of patients (80 percent), intermediate in 14 patients and high in six patients.

Isotemporal substitution models revealed that when 10 minutes of sedentary behaviour were reallocated to MVPA, there were significant reductions observed in systolic (β, –2.15 mm Hg; p=0.01) and diastolic blood pressure (β, –1.56 mm Hg; p=0.01), as well as in estimated 10-year CVD risk (relative rate [RR], 0.81, 95 percent confidence interval [CI], 0.70–0.93).

Furthermore, time reallocation from light PA to MVPA led to lower diastolic blood pressure (β, –1.45 mm Hg; p=0.01) and 10-year CVD risk estimates (RR, 0.80, 95 percent CI, 0.69–0.94).

In light of the findings, PA interventions should address suboptimal MVPA levels to improve cardiovascular risk in the SLE population, according to the researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.